Professional Documents
Culture Documents
MSDS 80%
MSDS 80%
MSDS 80%
Sodium Chlorite 80 %
SECTION 1 CHEMICAL PRODUCT AND COMPANY IDENTIFICATION
PRODUCT NAME
Sodium Chlorite 80 %
CHEMICAL NAME SYNONYMS
Sodium Chlorite, Dry Chlorous Acid, Sodium Salt
MANUFACTURER
SHREE CHLORATES PVT. LTD.
101-102, Block ‘B’ Radhakrishna Complex,
10/1, Manoramaganj, A.B.Road,
INDORE- 452 001 INDIA
Tel: 91 731 2490172,2491495,
E-Mail: shree@shreechlorates.com
Website : www.shreechlorates.com
EMERGENCY OVERVIEW
White Powder, slight chlorine odor DANGER! Strong oxidizer, contact with other material may cause fire.
Causes skin and eye irritation May cause burns when moist. Harmful if swallowed. Causes digestive tract
burns.
Precautionary statements (GHS-US) : P210 - Keep away from heat, sparks, open flames, hot surfaces. - No smoking.
P220 - Keep/Store away from clothing, combustible materials
P221 - Take any precaution to avoid mixing with combustibles
P260 - Do not breathe dust.
P262 - Do not get in eyes, on skin, or on clothing.
P264 - Wash exposed skin thoroughly after handling.
P270 - Do not eat, drink or smoke when using this product.
P271 - Use only outdoors or in a well-ventilated area.
P273 - Avoid release to the environment.
P280 - Wear protective gloves, protective clothing, eye protection, face protection.
P284 - Wear respiratory protection.
P301+P330+P331 - IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P303+P361+P353 - IF ON SKIN (or hair): Remove/Take off immediately all contaminated
clothing. Rinse skin with water/shower.
P305+P351+P338 - If in eyes: Rinse cautiously with water for several minutes. Remove contact
lenses, if present and easy to do. Continue rinsing
P310 - Immediately call a poison center or doctor/physician.
P361 - Remove/Take off immediately all contaminated clothing
P363 - Wash contaminated clothing before reuse.
P370+P378 - In case of fire: Use carbon dioxide (CO2), powder, alcohol-resistant foam to
extinguish
P391 - Collect spillage.
P403+P233 - Store in a well-ventilated place. Keep container tightly closed.
P405 - Store locked up.
P501 - Dispose of contents/container to comply with local, state and federal regulations
If inhaled: Remove person to fresh air and keep comfortable for breathing
MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE: Preexisting disorders of the following organs or systems,
which may be aggravated by exposure to this material include: respiratory system (including asthma and
other breathing disorders), gastrointestinal system, skinandblood (anemia, G6PD deficiency).
EFFECTS FOLLOWING REPEATED EXPOSURE: This material may cause the following effects: respiratory tract
damage (nose, throat, airways), lung damage, gastrointestinal damage, skin damage. Observations in
animal studies include: blood disorders and male reproductive effects. The relevance of these observations
to humans is not clear at this time.
STORAGE
STORAGE CONDITIONS: Store at Room Temperature & sealed containers in well-ventilated area away from
heat or open flame.
To be kept away from heat, flammable substances, organic chemicals, Acids, etc.
Consult local fire codes. Keep containers tightly closed when not in use. Do not store in open, unlabeled or
mislabeled containers. Do not remove or deface label. Do not expose to direct light. Do not expose to moisture
during storage. Do not drop, roll or skid drums. Keep drums upright.
SHELF LIFE LIMITATIONS: 2 years
INCOMPATIBLE MATERIALS FOR STORAGE OR TRANSPORT: Acids, reducing agents, combustible material,
oxidizers (such as hypochlorites), paints, sulfur and solvents.
MUTAGENICITY: Sodium chlorite has been evaluated for possible mutagenic effects in several laboratory tests.
It has tested positive in the Ames Salmonella reverse mutation assay without metabolic activators and
caused chromosomal aberrations in an in vitro Chinese hamster fibroblast cell line without metabolic
activators. Sodium chlorite also tested positive in the mouse micronucleus assay when administered
intraperitoneally (directly into the body cavity), but was not mutagenic when administered orally. The
significance of these test results for human health is unclear because the oxidizing effects of the chlorite or
salting effects of sodium may significantly affect the ability of the tests to accurately detect mutagens.
REPRODUCTIVE/DEVELOPMENTAL TOXICITY : Groups of male rats exposed to 100 or 500 ppm sodium chlorite in
drinking water ad libitum showed a significant increase in the percentage of morphologically abnormal sperm
as well as a significant decrease in sperm motility. No effects on reproduction were reported. Sodium chlorite
has not been found to be teratogenic in studies in which animals have been exposed up to 100 ppm in the
drinking water.
The CMA conducted a two-generation reproductive rat study with developmental neurotoxicity to evaluate
the effects of sodium chlorite on reproduction and pre- and post-natal development when administered orally
via drinking water for two successive generations. Sodium chlorite was administered at 0, 35, 70, and 300
ppm in drinking water to male and female rats for ten weeks prior to mating. Dosing continued during the
mating period, pregnancy and lactation. The final report concluded that there were no meaningful treatment
related effects at any dose level for systemic, reproductive/ developmental, and developmental neurological
end points. Hematological effects and reduced body weight gains were observed in some treatment groups.
Contains nitrate which has been reported to induce methemoglobinemia in humans. There is evidence in
animals that the developing fetus may be particularly sensitive to the effects of methemoglobin formation.
according to Federal Register / Vol. 77, No. 58 / Monday, March 26, 2012 / Rules and Regulations
Revision No.4 pg. 5 Rev. Date: 1.1.2021
Emergency Information: For any other information contact:
SHREE CHLORATES PVT. LTD.
101-102, Block ‘B’ Radhakrishna Complex,
10/1, Manoramaganj, A.B.Road,
INDORE- 452 001 INDIA
Tel: 91 731 2490172,2491495
E-Mail: shree@shreechlorates.com
Web : www.shreechlorates.com
*****
according to Federal Register / Vol. 77, No. 58 / Monday, March 26, 2012 / Rules and Regulations
Revision No.4 pg. 6 Rev. Date: 1.1.2021